spot_img

about fansalaran

FanSalaran is a comprehensive media platform dedicated to reporting and clarifying the significant achievements of pharmaceutical companies. In collaboration with passionate and motivated young journalists, this website consistently strives to showcase the country's successes in order to inspire and encourage the hardworking individuals of this land.

Singapore’s Ministry of Health Signs Landmark Agreement to Become Pioneer Country in HealthAI’s Global Regulatory Network

The Global Agency for Responsible AI in Health, today welcomes Singapore as a pioneer country joining the HealthAI Global Regulatory Network (GRN), a global network of health regulators dedicated to the safe and effective use of AI in healthcare. The agreement signed today marks the start of a collaboration between Singapore’s Ministry of Health (MOH) and HealthAI to share best practices and information aimed at accelerating global efforts for safer and more effective deployment of AI in healthcare, as well as contribute to regulatory solutions such as a “Global Public Directory of AI-related Registered Solutions for Health.”

This strengthens Singapore’s position as a leader in the responsible adoption of AI across healthcare and represents a milestone in HealthAI’s objective to foster global collaboration for equitable, safe and effective AI-driven health solutions. The first cohort of ten Pioneer Countries is slated to launch by Q3 2025. Singapore is the first Asian nation to join this inaugural cohort.

The signing also reaffirms Singapore’s commitment to improving health outcomes for its own citizens while nurturing a regional ecosystem where neighbouring countries can engage, exchange ideas, and explore opportunities to meaningfully advance the responsible use of AI in healthcare.

Hot this week

Daewoong Pharmaceutical Holds Talks with Saudi Officials on Bioindustry Cooperation

Daewoong Pharmaceutical said on October 17 that it met...

Novo Nordisk chair and independent directors to exit in strategy dispute

The chair of Wegovy maker Novo Nordisk and six...

Hologic to go private in up to $18.3 billion deal backed by Blackstone, TPG

Medical diagnostics firm Hologic has agreed to be acquired...

China’s Innovent signs $11.4 billion cancer therapy deal with Japan’s Takeda

-China’s Innovent Biologics said on Wednesday it had signed...

Topics

spot_img

Related Articles

Popular Categories

spot_imgspot_img